Valeur202020212022202320242025TTMFlux de trésorerie liés aux activités d'investissement-5.03 M-5.8 M-3.32 M5.83 M-215 K-634 K-434 KFlux de trésorerie liés aux activités de financement1.33 M70.52 M94.98 M5.39 M50.45 M95.16 M85.22 MFlux de trésorerie disponible-92.42 M-15.91 M-49.07 M-86.07 M-58.7 M-65.93 M-58.77 M
Precision BioSciences, Inc. - Common Stock
Precision BioSciences, Inc. is a publicly traded American clinical stage gene editing company headquartered in Durham, North Carolina. Founded in 2006, Precision is focused on developing both in vivo and ex vivo gene editing therapies using its proprietary "ARCUS" genome editing platform.